Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Five-year survival outcomes for patients with advanced me... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
0
Authors
Omid Hamid
21 more
Omid Hamid
•
Caroline Robert
19 more
•
Antoni Ribas
Published
January 29, 2019
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Annals of Oncology
Topics
Medicine
Cancer Oncology
Immunology
Internal Medicine
Surgery
Show all topics
DOI
10.1093/annonc/mdz011
License
CC-BY-NC
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Annals of Oncology
Topics
Medicine
Cancer Oncology
Immunology
Internal Medicine
Surgery
Show all topics
DOI
10.1093/annonc/mdz011
License
CC-BY-NC
Other Formats
PDF
